Feasibility of telemonitoring in hematology patients: a narrative review
https://doi.org/10.25881/18110193_2025_1_22
Abstract
Literature data presented in open medical sources on the use of telemedicine in hematology were analyzed. Telemedicine is an effective way to manage and monitor patients in order to minimize in-person hospital visits when this can be avoided. The experience and perspectives of this type of interaction in terms of patient satisfaction and effectiveness in monitoring various hematologic diseases have been studied. Despite the small number of results with high evidence, the studies demonstrate an optimistic picture of the use of telemedicine in real clinical practice, which leads to the need for more large-scale and high-quality studies to introduce various forms of telemonitoring in the routine follow-up of hematologic patients.
About the Authors
P. V. Osadchaya
Federal State Budgetary Educational Institution Samara State Medical University of the Russian Ministry of Health
Russian Federation
Russian Federation
Samara
A. A. Garanin
Federal State Budgetary Educational Institution Samara State Medical University of the Russian Ministry of Health
Russian Federation
Russian Federation
PhD
Samara
I. L. Davydkin
Federal State Budgetary Educational Institution Samara State Medical University of the Russian Ministry of Health
Russian Federation
Russian Federation
DSc, Professor
Samara
References
1. Mussetti A, Peric Z, Figueroa C. COVID19 in hematological patients and telemedicine: lessons learned across Europe and the US. Current Opinion in Infectious Diseases. 2022; 35(4): 295-01. doi: 10.1097/qco.0000000000000843.
2. Sheshunova RA. Establishing and development of hematology service in Russia. Science and Innovations in Medicine. 2019; 4(1): 42-47. (In Russ.) doi: 10.35693/2500-1388-2019-4-1-42-47.
3. Lukina KA, Zaitsev DA, Garmaeva TC, Mendeleeva LP. Telemedicine as an instrument of interregional remote interaction with specialized medical organizations of the subjects of the Russian Federation: 5-year experience of the Federal State Budgetary Institution "NMIC of Hematology" of the Ministry of Health of the Russian Federation. Doctor and information technology. 2020; 4: 68-77. (In Russ.) doi: 10.37690/1811-0193-2020-4-68-77.
4. Lagutin MD, Samofalov DA, Tyufilin DS, Chigrina VP, Kilimnik AI, Kobyakova OS. In the trend of providing telemedicine services by federal centers of the Russian Federation. Social aspects of public health online edition. 2024; 70(2): 1. Achievement mode: http://vestnik.mednet.ru/content/view/1581/27/lang,ru/. (In Russ.) doi: 10.21045/2071-5021-2024-70-2-1.
5. Ivanova AA, Zavaleva EV, Pavlyuk AV, Novichkova GA. Possibilities, problems and prospects of application of telemedicine technologies in the field of pediatric hematology. Issues of hematology/oncology and immunopathology in pediatrics. 2020; 19(3): 189-193. (In Russ.) doi: 10.24287/1726-1708-2020-19-3-189-193.
6. Federal’nyi zakon № 323-FZ ot 21 noyabrya 2011 goda «Ob osnovah ohrany zdorov'ya grazhdan v Rossijskoj Federacii». Available from: https://minzdrav.gov.ru/documents/7025-federalnyy-zakon-ot-21-noyabrya-2011-g-323-fz-ob-osnovah-ohrany-zdorovya-grazhdan-v-rossiyskoy-federatsii (In Russ.)
7. Shah AC, O'Dwyer LC, Badawy SM. Telemedicine in Malignant and Nonmalignant Hematology: Systematic Review of Pediatric and Adult Studies. JMIR Mhealth Uhealth. 2021; 9(7): e29619. doi: 10.2196/29619.
8. Jacobsen M, Rottmann P, Dembek TA et al. Feasibility of Wearable-Based Remote Monitoring in Patients During Intensive Treatment for Aggressive Hematologic Malignancies. JCO Clinical Cancer Informatics. 2022; 6. doi: 10.1200/CCI.21.00126.
9. Nawas MT, Landau HJ, Sauter CS et al. Pilot Study of Telehealth Evaluations in Patients Undergoing Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantatio. 2020; 26(6): e135-7. doi: 10.1016/j.bbmt.2020.02.004.
10. Chang E, Iukuridze A, Echevarria M, et al. Feasibility and Acceptability of Using a Telehealth Platform to Monitor Cardiovascular Risk Factors in Hematopoietic Cell Transplantation Survivors at Risk for Cardiovascular Disease. Biology of Blood and Marrow Transplantation. 2020; 26(6): 1233-7. doi: 10.1016/j.bbmt.2020.02.027.
11. Turner J, He Q, Baker K, et al. Home Spirometry Telemonitoring for Early Detection of Bronchiolitis Obliterans Syndrome in Patients with Chronic Graft-versus-Host Disease. Transplantation and Cellular Therapy. 2021; 27(7): 616.e1-616.e6. doi: 10.1016/j.jtct.2021.03.024.
12. Postorino M, Treglia M, Giammatteo J, et al. Telemedicine as a Medical Examination Tool During the Covid-19 Emergency: The Experience of the Onco-Haematology Center of Tor Vergata Hospital in Rome. Int J Environ Res Public Health. 2020; 17(23): 8834. doi: 10.3390/ijerph17238834.
13. Palandri F, Bartoletti D, Giaquinta S, et al. Telemedicine in patients with haematological diseases during the coronavirus disease 2019 (COVID-19) pandemic: selection criteria and patients’ satisfaction. British Journal of Haematology. 2020; 192(2). doi: 10.1111/bjh.17208.
14. Darcourt JG, Aparicio K, Dorsey PM et al. Analysis of the Implementation of Telehealth Visits for Care of Patients With Cancer in Houston During the COVID-19 Pandemic. JCO Oncology Practice. 2021; 17(1): e36-43. doi: 10.1200/op.20.00572.
15. Kumar P, Aggarwal M, Dhawan R, et al. Tele-Medicine Services in Hematological Practice During Covid Pandemic: Its Feasibility and Difficulties. Indian Journal of Hematology and Blood Transfusion. 2020; 37(4): 528-33. doi: 10.1007/s12288-020-01385-7.
16. Mussetti A, Salas MQ, Condom M, et al. Use of Telehealth for Domiciliary Follow-up After Hematopoietic Cell Transplantation During the COVID-19 Pandemic: Prospective Pilot Study. JMIR Formative Research. 2021; 5(3): e26121. doi: 10.2196/26121.
17. Lupo-Stanghellini MT, Messina C, Marktel S, et al. Following-up allogeneic transplantation recipients during the COVID-19 pandemic. The Lancet Haematology. 2020; 7(8): e564-5. doi: 10.1016/s2352-3026(20)30176-9.
18. Paludo J, Bansal R, Holland AT, et al. Pilot Implementation of Remote Patient Monitoring Program for Outpatient Management of CAR-T Cell Therapy. Blood. 2021; 138(S1): 568-568. doi: 10.1182/blood-2021-149103.
Review
For citations:
Osadchaya P.V., Garanin A.A., Davydkin I.L. Feasibility of telemonitoring in hematology patients: a narrative review. Medical Doctor and Information Technologies. 2025;(1):22-29. (In Russ.) https://doi.org/10.25881/18110193_2025_1_22
Views:
467
Email this article 